Cargando…
POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923527/ https://www.ncbi.nlm.nih.gov/pubmed/35469670 http://dx.doi.org/10.1016/j.chest.2022.01.036 |
| _version_ | 1784669693351559168 |
|---|---|
| author | Tritschler, Tobias Le Gal, Grégoire Brosnahan, Shari Carrier, Marc |
| author_facet | Tritschler, Tobias Le Gal, Grégoire Brosnahan, Shari Carrier, Marc |
| author_sort | Tritschler, Tobias |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8923527 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American College of Chest Physicians. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89235272022-03-15 POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes Tritschler, Tobias Le Gal, Grégoire Brosnahan, Shari Carrier, Marc Chest Editorial: Point and Counterpoint American College of Chest Physicians. Published by Elsevier Inc. 2022-06 2022-03-15 /pmc/articles/PMC8923527/ /pubmed/35469670 http://dx.doi.org/10.1016/j.chest.2022.01.036 Text en © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial: Point and Counterpoint Tritschler, Tobias Le Gal, Grégoire Brosnahan, Shari Carrier, Marc POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes |
| title | POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes |
| title_full | POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes |
| title_fullStr | POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes |
| title_full_unstemmed | POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes |
| title_short | POINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? Yes |
| title_sort | point: should therapeutic heparin be administered to acutely ill hospitalized patients with covid-19? yes |
| topic | Editorial: Point and Counterpoint |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923527/ https://www.ncbi.nlm.nih.gov/pubmed/35469670 http://dx.doi.org/10.1016/j.chest.2022.01.036 |
| work_keys_str_mv | AT tritschlertobias pointshouldtherapeuticheparinbeadministeredtoacutelyillhospitalizedpatientswithcovid19yes AT legalgregoire pointshouldtherapeuticheparinbeadministeredtoacutelyillhospitalizedpatientswithcovid19yes AT brosnahanshari pointshouldtherapeuticheparinbeadministeredtoacutelyillhospitalizedpatientswithcovid19yes AT carriermarc pointshouldtherapeuticheparinbeadministeredtoacutelyillhospitalizedpatientswithcovid19yes |